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Abstract
Background: Although test-retest reliability of mean values of spatio-temporal gait parameters has been assessed
for reliability while walking alone (i.e., single tasking), little is known about the test-retest reliability of stride time
variability (STV) while performing an attention demanding-task (i.e., dual tasking). The objective of this study was to
examine immediate test-retest reliability of STV while single and dual tasking in cognitively healthy older
individuals (CHI) and in demented patients with frontotemporal degeneration (FTD).
Methods: Based on a cross-sectional design, 69 community-dwelling CHI (mean age 75.5 ± 4.3; 43.5% women)
and 14 demented patients with FTD (mean age 65.7 ± 9.8 years; 6.7% women) walked alone (without performing
an additional task; i.e., single tasking) and while counting backward (CB) aloud starting from 50 (i.e., dual tasking).
Each subject completed two trials for all the testing conditions. The mean value and the coefficient of variation
(CoV) of stride time while walking alone and while CB at self-selected walking speed were measured using
GAITRite® and SMTEC® footswitch systems.
Results: ICC of mean value in CHI under both walking conditions were higher than ICC of demented patients with
FTD and indicated perfect reliability (ICC > 0.80). Reliability of mean value was better while single tasking than dual
tasking in CHI (ICC = 0.96 under single-task and ICC = 0.86 under dual-task), whereas it was the opposite in
demented patients (ICC = 0.65 under single-task and ICC = 0.81 under dual-task). ICC of CoV was slight to poor
whatever the group of participants and the walking condition (ICC < 0.20), except while dual tasking in demented
patients where it was fair (ICC = 0.34).
Conclusions: The immediate test-retest reliability of the mean value of stride time in single and dual tasking was
good in older CHI as well as in demented patients with FTD. In contrast, the variability of stride time was low in
both groups of participants.
Background
Stride time variability (STV), as measured by the coeffi-
cient of variation (CoV), is considered as a marker for the
control of limb-coordinated movements [1,2]. In terms of
gait control, a low variability of STV while steady state
walking reflects an automatic process requiring minimal
attention, whereas a high variability is related to major
attention involvement [3]. Dual-task paradigms are used
by clinicians to evaluate the cortical involvement in gait
control [4]. Changes in gait performance while performing
an attention-demanding task compared to walking alone
result from interference caused by competing demands for
attention resources and depend in part on the efficiency of
executive functions [4-6].
Demented older adults demonstrate greater gait
impairments than those expected with normal aging pro-
cess [7,8]. In particular, frontal lobe dysfunction has been
associated with gait disorders in dementia [5,6,9]. Thus,
exploring gait variability under single and dual tasking in
demented patients with frontotemporal degeneration
(FTD) and in cognitively healthy individuals (CHI) might
improve our understanding of higher-level gait disorders
in dementia.
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Counting backward (CB) is an attention-demanding task
frequently used in dual task paradigm involving gait [4].
Compared with other attention-demanding tasks used in
dual-task paradigms involving gait, CB has been previously
associated with high gait changes in demented patients
with impaired executive functions [5,6,9]. For instance, it
has been reported that patients with Alzheimer’s disease
(AD) or mixed dementia presenting with impaired execu-
tive functions exhibited an increase in STV during single
and dual tasking compared to non-demented counterparts
[5,9]. It has also been reported in a group of demented
patients with impaired executive functions that changes in
CoV of stride time while CB reflected the best dual-task
interference [6].
STV may be interpreted as surrogate marker for gait
control only after it has been determined if dual-task-
related changes of STV are due to a pathological process
affecting older adults, to a normal biological variability fol-
lowing consecutive gait measures from trial to trial or to a
measurement error. Although test-retest reliability of
mean values of spatio-temporal gait parameters has been
assessed for reliability while walking alone, little is known
on the test-retest reliability of gait variability while dual
tasking [10-12]. Recently, Hollman et al. showed in healthy
older adults that immediate test-retest reliability for varia-
bility in stride velocity was poor while dual tasking [11].
There is a lack of data for the test-retest reliability of STV
under single and dual-task conditions. The objective of
this study was to examine immediate test-retest reliability
of STV while single and dual tasking in CHI and in
demented patients with FTD.
Methods
Out of 80 community-dwelling CHI participating in a
large fall prevention program in Erlangen, Germany, 69
(90.0%) CHI (mean age 75.5 ± 4.3; 43.5% women) with at
least 3 consecutive measured gait cycles were included in
this study, with respect to the European guidelines for
clinical applications of spatio-temporal gait analysis in
older adults [13]. In addition, 14 consecutive demented
patients (mean age 65.7 ± 9.8 years; 6.7% women) with
FTD followed in a memory center in Paris, France, were
also included in the study. The selection of CHI has been
described elsewhere in details [14]. In summary, CHI
were drawn from a health insurance company member-
ship database. They were excluded if they were unable to
walk independently, were under 70 years of age or had
cognitive impairment. For the demented patients, diagno-
sis of FTD was based on the revised Lund and Manche-
ster criteria [15]. Dementia severity was measured with
the Mini-Mental State Examination (MMSE) [16] and
impairment in EF using the Frontal Assessment Battery
(FAB) [17]. A FAB score of 18 indicates normal executive
functions. The mean duration of disease for FTD group
was 4.2 ± 1.9 years. Demented patients took 3.9 ± 2.5
drugs per day on average. The mean MMSE score (/30)
and the mean FAB score (/18) were respectiveley 23.3 ±
6.6 and 12.6 ± 3.8. Exclusion criteria for FTD consisted
in extrapyramidal rigidity of the upper limbs with a score
above 2, based on item 22 of the Unified Parkinson’s Dis-
ease Rating Scale motor score (UPDRS)-motor score
[18]; acute medical illness in the past 3 months; neurolo-
gical and psychiatric diseases except dementia; severe
orthopaedic or rheumatologic conditions affecting nor-
mal walking, as well as use of walking aids. Written
informed consent was either obtained from the subject
or from their legal representative in case of cognitive
decline. The study was conducted in accordance with the
ethical standards set forth in the Helsinki Declaration
(1983). Each local ethics committee approved the project.
The mean value and the CoV (CoV = [standard devia-
tion/mean] × 100) of stride time while walking alone
(i.e., single tasking) and while counting backward (CB)
aloud starting from 50 (i.e., dual tasking) were collected.
Gait measurements were made according to the guide-
lines for clinical applications of spatio-temporal gait
analysis in older adults [13]. The mean value and the
CoV of stride time were measured at self-selected walk-
ing speed and while steady state walking using GAI-
TRite® and SMTEC® footswitches systems which are
two validated devices providing similar measures of
stride time [19]. The GAITRite® system is an electronic
walkway-integrated, pressure-sensitive electronic surface
connected to a personal portable computer via an inter-
face cable. The SMTEC® footswitches system is a pair
of innersoles fitted inside the subject’s shoes. Each
innersole contains 2 independent footswitches placed at
the heel and the toe, which are linked to a portable data
logger worn at the waist. To familiarize participants
using the SMTEC® system, each participant performed
one practice walk before recording.
The GAITRite® and the SMTEC® footswitches systems
used the same definition of stride time which was the time
elapsed between the first contacts of two consecutive foot-
falls of the same foot expressed in ms. Walking trials were
recorded on a 3.5-meter walkway for GAITRite® and
10-meters walkway for SMTEC®. To assure measuring of
steady-state walking among CHI, participants started
walking 2 meters before the active measuring electronic
surface area and stop 2 meters after. In the group of
demented patients with FTD, stride time parameters were
collected on a 14-meter long walkway but were analyzed
only over a distance of 10 meters. The first and last 2
meters corresponding to the acceleration and deceleration
phase of each pass were excluded from analysis. All parti-
cipants were asked to perform the walking tasks without
prioritizing walking or cognitive task. Before testing, a
trained evaluator gave standardized verbal instructions
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regarding the test procedure with a visual demonstration
of the walking test. Each subject completed two trials for
all the testing conditions. The walking trial was performed
in a well-lit environment. The participants walked at their
self-selected speed and wore their own footwear.
Immediate test-retest reliability of STV was evaluated
comparing the first and the second trial performed
while walking alone and while CB using intraclass corre-
lation coefficient (ICC). Separated analyses were used
for single and dual task condition. Using Landis and
Koch interpretation of agreement, an ICC > 0.80 indi-
cated almost perfect reliability, 0.61-0.80 substantial,
0.41-0.60 moderate, 0.21-0.40 fair, 0.00-0.20 slight,
below 0.0 poor [20]. P-values less than 0.05 were consid-
ered as statistically significant. All statistics were calcu-
lated using the Stata Statistical Software, version 11.1.
Results
All participants were able to complete single and dual-
task walking, without falling. As shown in Table 1, ICC
of mean value in CHI while single and dual tasking
were higher than ICC of demented patients with FTD
and indicated perfect reliability (ICC > 0.80). Reliability
of mean value was better while single tasking than dual
tasking in CHI (ICC = 0.96 under single-task and ICC =
0.86 under dual-task), whereas it was the opposite in
demented patients with FTD (ICC = 0.65 under single-
task and ICC = 0.81 under dual-task). ICC of CoV was
slight to poor, whatever the group of participants and
the walking condition (ICC < 0.20), except while dual
tasking in demented patients where ICC was fair (ICC =
0.34).
Discussion
Our results showed that the immediate test-retest relia-
bility of the mean value of stride time was perfect (i.e.,
ICC > 0.80), higher than the reliability of the CoV and
better in CHI than in demented patients with FTD. In
contrast, the reliability of the CoV was slight to poor in
both groups of participants, except while dual tasking in
the group of demented patients with FTD by whom it
was fair. In addition, the reliability of both stride para-
meters was better while dual tasking compared to single
tasking in demented patients with FTD but not in CHI.
The very good immediate test-retest reliability of
mean value of stride time while single tasking showed in
the studied sample of CHI and demented patients with
FTD is consistent with the literature. Indeed, previous
studies showed a high ICC for most temporo-spatial
gait parameters including stride time while walking
alone at usual walking speed [21-23]. Immediate test-
retest reliability of mean value of spatio-temporal gait
parameters while dual tasking has been few studied
compared to the single task condition. Our results high-
light a perfect reliability of the mean value (i.e., ICC >
80) while dual tasking based on Landis and Koch inter-
pretation of agreement [20] but under the reliability of
walking alone, except for demented patients. Like our
results, it has been recently shown that the ICC of the
mean value of velocity was slightly lower than the ICC
of mean value while single tasking in CHI [11]. In addi-
tion, we showed that ICC of the mean value of stride
time was better in CHI than in demented patients with
FTD. This result is also in concordance with the fact
that walking patterns of people with dementia are more
variable than those seen in normal ageing. This mainly
illustrates that, among demented patients, increased
variability occurs in both spatial and temporal gait mea-
sures leading to lower immediate test-retest reliability
than found among CHI [7,8,12].
In contrast to the mean value, little is known about
the test-retest reliability of stride-to-stride variability.
Our results show that the immediate reliability of the
CoV of stride time while single and dual tasking is poor,
which is in concordance with the few previous published
data. For instance, Hollman et al. recently reported
Table 1 Mean value and standard deviation of stride time parameters for two consecutively repeated trials while
walking alone awhile walking with counting backward among cognitively healthy individuals (n = 69) and demented
patients with frontotemporal dementia (n = 14)
Stride time
Mean value ICC Coefficient of variation ICC
Trial 1 Trial 2 Trial 1 Trial 2
Cognitively healthy individuals
Walking alone 1065.6 ± 105.3 1061.82 ± 104.0 0.96 1.3 ± 1.0 1.1 ± 0.8 -0.01
Walking with counting backward 1086.9 ± 183.5 1090.5 ± 225.1 0.86 1.7 ± 1.4 2.0 ± 3.3 0.11
Demented participants
Walking alone 1108.6 ± 90.2 1102.9 ± 83.4 0.65 5.0 ± 2.5 6.7 ± 4.6 -0.12
Walking with counting backward 1263.6 ± 124.5 1302.9 ± 131.2 0.81 7.6 ± 6.7 10.5 ± 9.3 0.34
±: Standard deviation.
ICC: Intra Class Coefficient Correlation
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among healthy older adults that immediate test-retest
reliability for variability in stride velocity was poor while
dual tasking [11]. This low reliability of CoV of stride
time indicates that the measurement lacks of consis-
tency for immediate test retest. Poor measurement relia-
bility generally comes from three main sources which
are the innate random variability from trial to trial, the
gait speed, and/or a measurement error. Because of the
very good immediate test-retest reliability of the mean
value of stride time, the methodology we used (i.e., com-
puterized walkway) for measuring gait characteristics
and a measurement error may be excluded. Variation of
gait speed between trials could explain the low reliability
of CoV of stride time. Indeed, it has been shown that
one of the main factors influencing the STV is walking
speed [24-26]. An increase in gait speed has been asso-
ciated with an increase in stride time variability. The
fact that we found a good reliability of mean value of
stride time ranging from perfect to substantial suggests
that participants, whatever their cognitive status, did not
vary their walking speed dramatically from one trial to
another. Therefore, the modest reliability of gait varia-
bility measures cannot be attributed to true between-
trial changes in walking speed, but seem to be related to
innate random variability.
Whilst the reliability of CoV was slight to poor in
most case, our results highlight that the reliability while
dual tasking in demented patients with FTD was higher
compared to single tasking (ICC = 0.34 while walking
with CB versus ICC = -0.12 while walking alone) and
compared to CHI (ICC = 0.11). One explanation could
be a practice effect related to the repetition of trials. We
showed that demented patients had a higher mean value
of CoV while dual tasking compared to CHI and com-
pared to walking alone, which is in concordance with
previously published data. We have earlier shown that
CB in demented participants with impaired EF provoked
severe perturbation in gait control resulting in an
increased CoV of stride time compared to the mean
value while dual tasking [5,6,9]. Thus, the fact that
demented patients with FTD had a higher mean value
of CoV than in CHI suggest that they were disturbed by
CB as well during the first as the second gait trials with
no motor skill effect. We observed a similar effect with
the mean value of stride time.
The main limitation of our study was the short length
of the walkway used to assess STV. The European GAI-
TRite network group recommends the highest number of
gait cycles possible from a practical standpoint, with a
minimum of three consecutive gait cycles [13]. Another
limitation could be in relation with the articulo-motor
components of enumerated figures which is different in
German and in French. However, it has been shown that
dual task-related stride time changes while CB in demen-
ted participants with frontal lobe dysfunction could not
be explained by the articulo-motor components of speech
[27].
Conclusions
Measurements of stride time variability had low
immediate test-retest reliability in older CHI as well as
in demented patients with FTD either in single or dual
task condition. In contrast, the reliability of the mean
value was good in both groups. This result suggests a
normal biological variability for stride time variability
between two immediate consecutive gait measurements.
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